Welltower (NYSE:WELL) Downgraded by StockNews.com

StockNews.com lowered shares of Welltower (NYSE:WELL) from a hold rating to a sell rating in a research report report published on Friday morning.

Several other brokerages have also recently weighed in on WELL. Wells Fargo & Company increased their price target on Welltower from $107.00 to $111.00 and gave the company an overweight rating in a research note on Thursday, May 30th. Evercore ISI upped their target price on Welltower from $95.00 to $97.00 and gave the company an in-line rating in a research report on Tuesday, July 16th. Mizuho upped their target price on Welltower from $98.00 to $105.00 and gave the company a buy rating in a research report on Wednesday, May 8th. Scotiabank upped their target price on Welltower from $96.00 to $108.00 and gave the company a sector outperform rating in a research report on Thursday, May 16th. Finally, Morgan Stanley upped their target price on Welltower from $103.00 to $107.50 and gave the company an overweight rating in a research report on Thursday, July 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and an average price target of $101.32.

Welltower Trading Up 1.2 %

Shares of WELL stock opened at $109.78 on Friday. The stock has a market cap of $65.64 billion, a price-to-earnings ratio of 135.53, a PEG ratio of 2.70 and a beta of 1.18. The stock has a 50-day moving average of $104.21 and a 200-day moving average of $96.35. The company has a current ratio of 3.83, a quick ratio of 3.83 and a debt-to-equity ratio of 0.50. Welltower has a 1-year low of $78.38 and a 1-year high of $111.85.

Welltower (NYSE:WELL) last issued its quarterly earnings results on Monday, April 29th. The real estate investment trust reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.94 by ($0.72). The company had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.81 billion. Welltower had a net margin of 6.37% and a return on equity of 1.77%. The company’s quarterly revenue was up 19.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.85 EPS. On average, equities research analysts forecast that Welltower will post 4.13 earnings per share for the current year.

Insiders Place Their Bets

In other Welltower news, Director Kenneth J. Bacon sold 1,800 shares of the stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $103.91, for a total value of $187,038.00. Following the transaction, the director now owns 14,579 shares in the company, valued at $1,514,903.89. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.12% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. TruNorth Capital Management LLC bought a new position in shares of Welltower in the second quarter valued at approximately $27,000. Rise Advisors LLC bought a new position in shares of Welltower in the first quarter valued at approximately $27,000. Manchester Capital Management LLC lifted its holdings in shares of Welltower by 338.7% in the first quarter. Manchester Capital Management LLC now owns 329 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 254 shares in the last quarter. Scarborough Advisors LLC bought a new position in shares of Welltower in the fourth quarter valued at approximately $35,000. Finally, Opal Wealth Advisors LLC bought a new position in shares of Welltower in the first quarter valued at approximately $43,000. Institutional investors own 94.80% of the company’s stock.

About Welltower

Welltower Inc (NYSE:WELL), a REIT and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.